Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Keratinocytes | 5 | 2004 | 9 | 0.340 |
Why?
|
| Papillomaviridae | 4 | 2005 | 25 | 0.290 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2003 | 88 | 0.260 |
Why?
|
| Secretin | 5 | 2003 | 13 | 0.240 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2002 | 19 | 0.220 |
Why?
|
| Head and Neck Neoplasms | 2 | 2002 | 13 | 0.220 |
Why?
|
| Tumor Virus Infections | 1 | 2002 | 10 | 0.180 |
Why?
|
| Papillomavirus Infections | 1 | 2002 | 27 | 0.180 |
Why?
|
| Transcriptional Activation | 3 | 2007 | 9 | 0.180 |
Why?
|
| Oncogene Proteins, Viral | 3 | 2007 | 7 | 0.160 |
Why?
|
| Transcription Factors | 2 | 2003 | 53 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1999 | 1 | 0.150 |
Why?
|
| Retinoblastoma Protein | 1 | 1999 | 3 | 0.150 |
Why?
|
| Transcription Factor AP-1 | 1 | 1999 | 7 | 0.150 |
Why?
|
| HIV-1 | 3 | 2004 | 36 | 0.150 |
Why?
|
| Gene Expression | 3 | 2003 | 77 | 0.130 |
Why?
|
| Base Sequence | 7 | 2004 | 65 | 0.120 |
Why?
|
| Repressor Proteins | 2 | 2007 | 13 | 0.120 |
Why?
|
| Cells, Cultured | 6 | 2004 | 234 | 0.100 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2003 | 17 | 0.100 |
Why?
|
| Ethanol | 2 | 2004 | 86 | 0.100 |
Why?
|
| Mouth Mucosa | 2 | 2003 | 13 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2003 | 29 | 0.090 |
Why?
|
| DNA Replication | 2 | 2002 | 2 | 0.090 |
Why?
|
| Operon | 1 | 1991 | 1 | 0.090 |
Why?
|
| Rhamnose | 1 | 1991 | 1 | 0.090 |
Why?
|
| Phosphotransferases | 1 | 1991 | 2 | 0.090 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1991 | 2 | 0.090 |
Why?
|
| Salmonella typhimurium | 1 | 1991 | 2 | 0.090 |
Why?
|
| Genes, Regulator | 1 | 1991 | 3 | 0.090 |
Why?
|
| Ethics Committees, Research | 1 | 2011 | 2 | 0.080 |
Why?
|
| Humans | 13 | 2011 | 6794 | 0.080 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 28 | 0.080 |
Why?
|
| Health Services Research | 1 | 2011 | 27 | 0.080 |
Why?
|
| Blotting, Northern | 5 | 2003 | 25 | 0.080 |
Why?
|
| Animals | 7 | 2005 | 1875 | 0.080 |
Why?
|
| Healthcare Disparities | 1 | 2011 | 83 | 0.080 |
Why?
|
| Molecular Sequence Data | 5 | 2003 | 70 | 0.070 |
Why?
|
| Cloning, Molecular | 2 | 2002 | 8 | 0.070 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2007 | 8 | 0.070 |
Why?
|
| Receptors, CXCR4 | 2 | 2004 | 4 | 0.070 |
Why?
|
| Carcinoma | 1 | 2007 | 13 | 0.070 |
Why?
|
| Mouth | 2 | 2004 | 2 | 0.060 |
Why?
|
| Neovascularization, Pathologic | 1 | 2007 | 23 | 0.060 |
Why?
|
| Metallothionein | 2 | 2003 | 4 | 0.060 |
Why?
|
| Cell Division | 3 | 2003 | 40 | 0.060 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2007 | 92 | 0.060 |
Why?
|
| Gingiva | 1 | 2005 | 1 | 0.060 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2005 | 4 | 0.060 |
Why?
|
| Proteins | 1 | 2005 | 41 | 0.060 |
Why?
|
| Cell Line | 3 | 2005 | 124 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 1997 | 120 | 0.050 |
Why?
|
| 3T3 Cells | 2 | 2005 | 12 | 0.050 |
Why?
|
| Apoptosis | 1 | 2005 | 179 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2004 | 94 | 0.050 |
Why?
|
| DNA Primers | 2 | 2004 | 23 | 0.050 |
Why?
|
| Escherichia coli Proteins | 1 | 2003 | 2 | 0.050 |
Why?
|
| Laryngeal Neoplasms | 1 | 2003 | 3 | 0.050 |
Why?
|
| Bacterial Toxins | 1 | 2003 | 6 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2003 | 17 | 0.050 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2003 | 1 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2003 | 10 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 38 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2003 | 45 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2001 | 101 | 0.050 |
Why?
|
| Oncogenes | 1 | 2002 | 4 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 1 | 2002 | 6 | 0.050 |
Why?
|
| Enzymes | 1 | 2002 | 5 | 0.050 |
Why?
|
| Growth Substances | 1 | 2002 | 10 | 0.050 |
Why?
|
| Mutagenesis | 1 | 2001 | 8 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2002 | 22 | 0.040 |
Why?
|
| DNA Repair | 1 | 2001 | 7 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2001 | 17 | 0.040 |
Why?
|
| DNA Damage | 1 | 2001 | 20 | 0.040 |
Why?
|
| Mice | 2 | 2005 | 746 | 0.040 |
Why?
|
| Plasmids | 3 | 2005 | 17 | 0.040 |
Why?
|
| RNA | 3 | 2003 | 25 | 0.040 |
Why?
|
| Transcription, Genetic | 3 | 2003 | 40 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 3 | 2003 | 7 | 0.040 |
Why?
|
| Amino Acid Sequence | 3 | 2003 | 38 | 0.040 |
Why?
|
| DNA, Viral | 3 | 2004 | 10 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 3 | 2004 | 43 | 0.040 |
Why?
|
| Adenovirus E1A Proteins | 1 | 1999 | 1 | 0.040 |
Why?
|
| Haplorhini | 1 | 1999 | 2 | 0.040 |
Why?
|
| Collagenases | 1 | 1999 | 3 | 0.040 |
Why?
|
| Binding Sites | 1 | 1999 | 24 | 0.040 |
Why?
|
| Protein Binding | 1 | 1999 | 29 | 0.040 |
Why?
|
| Transfection | 3 | 2007 | 56 | 0.040 |
Why?
|
| Flow Cytometry | 3 | 2004 | 48 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2003 | 8 | 0.040 |
Why?
|
| HIV Infections | 1 | 2003 | 432 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2004 | 190 | 0.030 |
Why?
|
| Mutation | 2 | 2003 | 97 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 1997 | 25 | 0.030 |
Why?
|
| Colon | 1 | 1997 | 20 | 0.030 |
Why?
|
| Papillomavirus E7 Proteins | 2 | 2007 | 4 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2007 | 15 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2007 | 26 | 0.030 |
Why?
|
| Cell Culture Techniques | 2 | 2005 | 18 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2003 | 118 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 1992 | 11 | 0.020 |
Why?
|
| Genomic Library | 1 | 1991 | 2 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 1991 | 2 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1991 | 10 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1991 | 8 | 0.020 |
Why?
|
| RNA Splicing | 1 | 1991 | 6 | 0.020 |
Why?
|
| Female | 3 | 2007 | 4060 | 0.020 |
Why?
|
| Biological Evolution | 1 | 1991 | 17 | 0.020 |
Why?
|
| Community-Institutional Relations | 1 | 2011 | 21 | 0.020 |
Why?
|
| Helix-Loop-Helix Motifs | 2 | 2003 | 2 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2003 | 9 | 0.020 |
Why?
|
| Rats | 3 | 1997 | 571 | 0.020 |
Why?
|
| Stilbenes | 1 | 2007 | 2 | 0.020 |
Why?
|
| Anticarcinogenic Agents | 1 | 2007 | 2 | 0.020 |
Why?
|
| Chromones | 1 | 2007 | 6 | 0.020 |
Why?
|
| Morpholines | 1 | 2007 | 6 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2007 | 11 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2007 | 10 | 0.020 |
Why?
|
| Flavonoids | 1 | 2007 | 6 | 0.020 |
Why?
|
| Middle Aged | 2 | 2003 | 2108 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 30 | 0.020 |
Why?
|
| United States | 1 | 2011 | 1019 | 0.020 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 2005 | 1 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2005 | 7 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 90 | 0.010 |
Why?
|
| Male | 2 | 2003 | 3671 | 0.010 |
Why?
|
| Receptors, HIV | 1 | 2003 | 1 | 0.010 |
Why?
|
| Clone Cells | 1 | 2003 | 2 | 0.010 |
Why?
|
| CD4 Antigens | 1 | 2003 | 4 | 0.010 |
Why?
|
| Proviruses | 1 | 2003 | 2 | 0.010 |
Why?
|
| Virus Replication | 1 | 2003 | 7 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 10 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2003 | 8 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2003 | 12 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2003 | 25 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 10 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2003 | 45 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2003 | 30 | 0.010 |
Why?
|
| Carbon-Oxygen Lyases | 1 | 2003 | 1 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 2 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2003 | 2 | 0.010 |
Why?
|
| Cricetinae | 1 | 2003 | 11 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2003 | 23 | 0.010 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2003 | 65 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2003 | 51 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2003 | 65 | 0.010 |
Why?
|
| Disease Progression | 1 | 2003 | 170 | 0.010 |
Why?
|
| Prognosis | 1 | 2003 | 220 | 0.010 |
Why?
|
| Temperature | 1 | 2001 | 8 | 0.010 |
Why?
|
| Protein Transport | 1 | 2001 | 23 | 0.010 |
Why?
|
| Cell Death | 1 | 2001 | 20 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 2001 | 1 | 0.010 |
Why?
|
| Time Factors | 1 | 2001 | 321 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2003 | 681 | 0.010 |
Why?
|
| Mammals | 1 | 1997 | 8 | 0.010 |
Why?
|
| Glucagonoma | 1 | 1992 | 1 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1992 | 1 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1992 | 6 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1992 | 9 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1992 | 49 | 0.010 |
Why?
|
| Intestine, Small | 1 | 1992 | 8 | 0.010 |
Why?
|
| Fetus | 1 | 1992 | 125 | 0.010 |
Why?
|
| Exons | 1 | 1991 | 8 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1991 | 6 | 0.010 |
Why?
|
| Glucagon | 1 | 1991 | 8 | 0.010 |
Why?
|
| Duodenum | 1 | 1991 | 4 | 0.010 |
Why?
|
| Cholecystokinin | 1 | 1991 | 18 | 0.010 |
Why?
|
| DNA | 1 | 1991 | 39 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 1992 | 100 | 0.010 |
Why?
|